Specific Diagnostics Receives Investment from Telegraph Hill Partners to Commercialize Critical Drug Susceptibility Technology for Clinical Microbiology Labs

VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.